Multiomics-Empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States

The study utilized multiomics analysis to investigate ulcerative colitis (UC) by examining tissue and plasma samples from 12 patients, identifying biomarkers that could indicate remission states and systemic effects. Despite clinical remission, some biomarkers, such as platelet-associated eicosanoids and certain metabolites, remained deregulated, suggesting persistent systemic alterations. The study highlighted the role of platelets in UC pathophysiology, with ongoing platelet activation potentially contributing to chronic inflammation and impaired tissue regeneration. These findings suggested that while some gut functions normalized upon remission, unresolved platelet activation and inflammation markers indicated ongoing disease processes. The study emphasized the need for prospective clinical studies to validate these biomarkers for prognostic use in UC treatment strategies.